NCT02736734View on ClinicalTrials.gov

The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Esophageal Motility Disorders
Interventions
DRUG

CRH

CRH injection: 100 µg CRH powder for injection (CRH Ferring) dissolved in 1ml NaCl 0.9%, administration intravenously over the course of 1 minute to avoid side effects.

Trial Locations (1)

3000

Targid, KU Leuven, Leuven

All Listed Sponsors
lead

Prof Dr Jan Tack

OTHER

NCT02736734 - The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers | Biotech Hunter | Biotech Hunter